Senior investor and operating executive with experience in private equity and corporate finance, focused on middle-market buyouts, growth equity and operational value creation. Christopher J. McKinley brings portfolio oversight, M&A execution and capital markets engagement skills, often leading turnaround programs, strategic carve-outs and EBITDA expansion initiatives. Background includes investor relations, deal sourcing and board-level governance; known for disciplined due diligence, hands-on operational improvement and fundraising across institutional limited partners.
Senior investor and operating executive with experience in private equity and corporate finance, focused on middle-market buyouts, growth equity and operational value creation. Christopher J. McKinley brings portfolio oversight, M&A execution and capital markets engagement skills, often leading turnaround programs, strategic carve-outs and EBITDA expansion initiatives. Background includes investor relations, deal sourcing and board-level governance; known for disciplined due diligence, hands-on operational improvement and fundraising across institutional limited partners.
Focuses on value-oriented middle-market private investments, privileging control or significant influence to drive operational turnarounds and EBITDA expansion. Employs rigorous due diligence and conservative capital structuring, blending buyout and growth-equity tactics to underwrite resilient cash flows. Prioritizes strategic carve-outs, repeatable M&A, and active board oversight, using hands-on operating levers to accelerate margin improvement. Time horizon is multi-year with emphasis on capital preservation, clear exit pathways via strategic sale or IPO, and disciplined LP alignment in fundraising.
Focuses on value-oriented middle-market private investments, privileging control or significant influence to drive operational turnarounds and EBITDA expansion. Employs rigorous due diligence and conservative capital structuring, blending buyout and growth-equity tactics to underwrite resilient cash flows. Prioritizes strategic carve-outs, repeatable M&A, and active board oversight, using hands-on operating levers to accelerate margin improvement. Time horizon is multi-year with emphasis on capital preservation, clear exit pathways via strategic sale or IPO, and disciplined LP alignment in fundraising.
| Trades 1298 | Longs Won 884/1298 68% | Profit Factor 9.98 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $553,210.37 |
| Average Win $172,821.52 | Best Trade (Oct 16) $9.5M | Sharpe Ratio -13.23 |
| Average Loss -$36,957.92 | Worst Trade (Oct 14) -$1.62M | Z-Score 11.99 (100%) |
| Commissions $0 | Avg. Trade Length 1y 10m 1w 2d | Expectancy $105,911.9 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 20,408 | 18,367 | 16,327 | 14,286 | 12,245 | 10,204 | 8,163 | 6,122 | 4,082 | 2,041 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 8,772 | $1.82M | $3.01M | - | $1.19M | 65.7% | +0.409% |
ABBV AbbVie Inc. | 2,979 | $531,572.54 | $843,593.22 | - | $312,020.68 | 58.7% | -0.078% |
ABT Abbott Laboratories | 2,503 | $305,715.56 | $263,140.39 | - | -$42,575.17 | -13.93% | +0.43% |
AGG iShares Core U.S. Aggregate Bond ETF | 36,373 | $3.5M | $3.47M | - | -$27,146.75 | -0.78% | -0.031% |
ALL Allstate Corporation | 1,000 | $207,070 | $242,960 | - | $35,890 | 17.33% | +1.402% |
AMZN Amazon.com Inc | 1,492 | $335,473.46 | $377,856.46 | - | $42,383 | 12.63% | -0.591% |
AVLV Avantis U.S. Large Cap Value ETF | 66,400 | $6.06M | $6.23M | - | $176,956 | 2.92% | +0.53% |
BCI abrdn Bloomberg All Commodity Strategy K-1 Free ETF | 26,531 | $571,903.84 | $694,979.54 | - | $123,075.7 | 21.52% | -0.248% |
BIL SPDR Bloomberg 1-3 Month T-Bill ETF | 10,197 | $933,631.57 | $933,586.33 | - | -$45.24 | - | +0.016% |
BKCI BNY Mellon ETF Trust BNY Mellon Concentrated International ETF | 10,458 | $513,844.55 | $557,202.24 | - | $43,357.69 | 8.44% | +0.585% |
BKLC BNY Mellon US Large Cap Core Equity ETF | 22,503 | $607,581 | $1.11M | - | $502,491.99 | 82.7% | 0.0 |
BND Vanguard Total Bond Market Index Fund | 8,916 | $649,070.12 | $631,252.8 | - | -$17,817.32 | -2.75% | -0.014% |
BRK-A Berkshire Hathaway Inc. | 8 | $5.84M | $6.32M | - | $473,288 | 8.1% | 0.0 |
BRK-B Berkshire Hathaway Inc. | 2,676 | $913,862.66 | $1.42M | - | $506,584.9 | 55.43% | +0.976% |
CGCP Capital Group Core Plus Income ETF | 171,672 | $3.88M | $3.68M | - | -$201,853.49 | -5.2% | -0.023% |
CGMU Capital Group Municipal Income ETF | 223,595 | $6.04M | $5.89M | - | -$150,814.19 | -2.5% | -0.057% |
CGXU Capital Group International Focus Equity ETF | 42,192 | $1.06M | $1.4M | - | $337,727.36 | 31.93% | -0.136% |
CSCO Cisco Systems, Inc. | 2,650 | $184,111.67 | $287,856.25 | - | $103,744.58 | 56.35% | -1.115% |
CVX Chevron Corporation | 1,690 | $277,218.96 | $375,011 | - | $97,792.04 | 35.28% | +1.176% |
DBMF iMGP DBi Managed Futures Strategy ETF | 8,197 | $247,139 | $268,738.64 | - | $21,599.64 | 8.74% | -0.137% |